In vitro characterization of carbamazepine-loaded Precifac lipospheres

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 13, Issue 2, 2006, Pages 95-104

  Barakat, Nahla S ^a   Yassin, Alaa Eldeen B ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Carbamazepine; Extended release; Lipospheres; Precifac

Indexed keywords

CARBAMAZEPINE; CETYLPALMITIC ACID; GELATIN; LIPID; PALMITIC ACID DERIVATIVE; PRECIFAC; UNCLASSIFIED DRUG; WATER;

ARTICLE; CONTROLLED DRUG RELEASE; DISPERSION; EMULSION; ENCAPSULATION; EXTENDED DRUG RELEASE; HYDROPHILICITY; LIPOPHILICITY; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY;

ANTICONVULSANTS; CARBAMAZEPINE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; LIPOSOMES; MICROSPHERES; PARTICLE SIZE;

EID: 31544443007     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540500313661     Document Type: Article

References (41)

1. Adeyeye, C., and Price, J. 1991. Development and evaluation of sustained-release ibuprofen-wax microspheres I. Effect of formulation variables on physical characteristics. Pharmaceut. Res. 8:1377-1384.
2. AHFS Drug Information 90. 1990. McEvoy, G. K., ed. Bethesda, MD: American Society of Hospital Pharmacists; 1142-1145.
3. Akiyama, Y., Yoshioka, M., Horibe, H., Hirai, S., Kitamori, N., and Toguchi, H. 1993. Novel oral controlled-release microspheres using polyglyceral esters of fatty acids. J. Control. Rel. 26:1-10.
4. Aldenkamp, A., Alpherts, W., Moreland, M., Ottevanger, N., and Van Parys, J. 1987. Controlled release carbamazepine: cognitive side effects in patients with epilepsy. Epilepsia 28:507-514.
5. Arshady, R. 1990. Albumin microspheres and microcapsules: methodology of manufacturing techniques. J. Control. Rel. 14:111-131.
6. Babay, D., Hoffman, A., and Benita, S. 1988. Design and release kinetic pattern evaluation of indomethacin microspheres intended for oral administration. Biomaterials 9:482-488.
7. Benita, S., Zouai, O., and Benoit, J. P. 1986. 5-Fluorouracil: carnauba wax microspheres for chemoembolization: an in vitro evaluation. J. Pharmaceut. Sci. 75:847-851.
8. Bertilsson, L., and Tomson, T. 1986. Clinical pharmacokinetics and pharmacological effect of Carbamazepine and Carbamazepine-10, 11-epoxide: an update. Clin. Pharmacokin. 11:177-198.
9. Cèolin, R., Toscani, S., Gardette, M.-F., Agafonov, V., Dzyabchenko, A., and Bachet, B. 1997. X-ray characterization of the triclinic polymorph of charpamazepine. J. Pharmaceut. Sci. 86:1062-1065.
10. Das, S., and Gupta, B. 1988. Optimisation of controlled drug release through micropelletization. Drug Devel. Ind. Pharm. 14:1673-1697.
11. Draper, E., and Becker, C. 1966. Some wax formulations of sulfaethylthiazidiazole produced by aqueous dispersion for prolonged release medication. J. Pharmceut. Sci. 55:376-380.
12. Faigle, J., and Feldman, K. 1989. Carbamazepine-biotransformation In Antiepileptic Drugs, 3rd ed., New York: Raven Press, 491-504.
13. Gattefosse Corporation: Information Forum for Pharmaceutical Formulator: the right mix. 1989. 3: 1.
14. Giannola, L., De Caro, V., and Di Stefano, V. 1994. Comparative in vitro evaluation of cumulative release of the urinary antiseptic nalidixic acid, pipemidic acid, cioxacin and norfloxacin from white beeswax microspheres. Drug Devel. Ind. Pharm. 20:2285-2297.
15. Giannola, L., De Caro, V., and Severino, A. 1995. Carnauba wax microspheres loaded with valproic acid: preparation and evaluation of drug release. Drug Devel. Ind. Pharm. 21:1563-1572.
16. Gohel, M., and Amin, A., 1997. Development and evaluation of lipospheres of diclophenac sodium. Ind. J. Pharmaceut. Sci. 59:85-88.
17. Hassan, E., Eshra, A., and Nada, A. 1994. Formulation of prolonged release lipid micropellets by emulsion congealing. Optimization of ketoprofen entrapment and release. Int. J. Pharmaceut. 121:149-155.
18. James, E., Singh, G., Larry, L., and Vinod, P. 1997. Method to compare dissolution profiles and a rationale for wide dissolution specification for metoprolol tartrate tablets. J. Pharmceut. Sci. 86:690-700.
19. Joseph, N. Lakshmi, S., and Jayakrishnan, A. 2002. A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits. J. Control. Rel. 79:71-79.
20. Karasulu, E., Karasulu, H., Ertan, G., Kirilmaz, L., and Guneri, T. 2003. Extended release lipophilicindomethacin microspheres: formulation factors and mathematical equations fitted drug release rates. Eur. J. Pharmaceut. Sci. 19:99-104.
21. Kawashima, Y., Ohno, H., and Takenaka, H. 1981. Preparation of spherical matrixes of prolonged-release drugs from liquid suspension. J. Pharmaceut. Sci. 70:913-916.
22. Kawata, M., Nakamura, M., Goto, S., and Aoyama, T. 1986. Preparation and dissolution pattern of Eudragit RS microcapsules containing ketoprofen. Chem. Pharmaceut. Bull. 34: 2618-2623.
23. Kiliçarslan, M., and Baykara, T. 2003. The effect of the drug/polymer ratio on the properties of the verapamil HCL loaded microspheres. Inter. J. Pharmaceut. 252: 99-109.
24. Kowarski, C., Volberger, B., Versanno, J., and Kowarski, A. 1964. A method of preparing sustained release sulfamethazine in small size batches. Am. J. Hosp. Pharm. 21: 409-410.
25. Krahn, F.U., and Mielck, J.B. 1989. Effect of type and extent of crystalline order on chemical and physical stability of carbamazepine. Inter. J. Pharmaceut. 53: 25-34.
26. Lefebvre, C., Guyot-Hermann, A.M., Draguet-Brugmans, M., Bouche, R., and Guyot, J.C. 1986. Polymorphic transitions of carbamazepine during grinding and compression. Drug Devel. Ind. Pharm. 12: 1913-1927.
27. Lovrecich, M., Orzincolo, O., and Rubersa, F. 1994. Physicochemical aspects upon the dissolution behavior of different forms of Carbamazepine. Acta Technol. Legis. Med. 5:29-48.
28. Macdonald, R. 1989. In Ahtiepileptic Drugs, 3rd ed. Levy, R. H., Mattson, R. H., Meldrum, B. S., and Penry, J. K., eds. New York: Press Raven, 447-455.
29. Malamatois, S., Panagopoulou, A., and Hatzipantou, P. 1991. Controlled release from glycerol palmito-stearate matrices prepared by dry heat granulation and compression at elevated temperature. Drug Devel. Ind. Pharm. 17:1765-1777.
30. Miyagawa, Y., Okabe, T., Yamaguchi, Y., Miyajimo, M., Sato, H., and Sunada, H. 1996. Controlled-release of diclofenac sodium from wax matrix granule. Inter. J. Pharmaceut. 138:215-224.
31. Naidoo, N. 1989. Encapsulation and in-vitro release of indomethacin from semi-solid matrix capsules. Inter. J. Pharmaceut. 55:53-57.
32. Naima, Z., Toscani, S., Gines-Dorado, J.-M., Chemtob, C., Cèolin, R., and Duguè, J. 2001. Interactions between carbamazepine and polyethylene glycol (PEG) 6000: characterizations of the physical solid dispersed and eutectic mixtures. Eur. J. Pharmaceut. Sci. 12:395-404.
33. Pongpaibul, Y., Price, J., and Whitworth, C. 1984. Preparation and evaluation of controlled release indomethacin microspheres. Drug Devel. Ind. Pharm. 10:1597-1616.
34. Porter, R. 1989. General principles: how to use antiepileptic drugs. In Antiepileptic Drugs, 3rd ed. New York, Raven Press, 117-131.
35. Rustichelli, C., Gamberini, G., Ferioli, V., Gamberini, M.C., Ficarra, R., and Tommasini, S. 2000. Solid-state study of polymorphic drugs: carbamazepine. J. Pharmaceut. Biomed. Anal. 23:41-54.
36. Sato, H., Miyagawa, Y., Okabe, T., Miyajma, M., and Sunada, H. 1997. Dissolution mechanism of diclofenac sodium from wax matrix granules. Inter. J. Pharmaceut. 86:929-934.
37. Schwartz, J. Simonelli, A., and Higuchi, W. 1968a. Drug release from wax matrices I: analysis of data with first-order kinetics and with the diffusion-controlled model. J. Pharmaceut. Sci. 57:274-277.
38. Schwartz, J., Simonelli, A., and Higuchi, W. 1968b. Drug release from wax matrices II: application of a mixture theory to the sulfanilamide-wax system. J. Pharmaceut. Sci. 57:278-282.
39. Wong, L., Gilligan, C., and Li Wan Po, A. 1992. Preparation and characterization of sustained-release ibuprofen-cetostearyl alcohol spheres. Inter. J. Pharmaceut. 83:95-114.
40. Wu, P., Tsai, M., Huang, Y., Chang, J., and Tsai, Y. 2002. In vitro and in vivo evaluation of potassium chloride sustained release formulation prepared with polyglycolyed glycerides matrices. Inter. J. Pharmaceut. 243:119-124.
41. Yamamoto, R., and Baba, M. Jap. Patent No. 1849 (1960).